BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31228011)

  • 1. Pluripotent Stem Cell-Derived Cardiomyocyte Transplantation for Heart Disease Treatment.
    Kadota S; Shiba Y
    Curr Cardiol Rep; 2019 Jun; 21(8):73. PubMed ID: 31228011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart regeneration using pluripotent stem cells.
    Kadota S; Tanaka Y; Shiba Y
    J Cardiol; 2020 Nov; 76(5):459-463. PubMed ID: 32690435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal Transplantation Confers Maturation of PSC-Derived Cardiomyocytes Conducive to Modeling Cardiomyopathy.
    Cho GS; Lee DI; Tampakakis E; Murphy S; Andersen P; Uosaki H; Chelko S; Chakir K; Hong I; Seo K; Chen HV; Chen X; Basso C; Houser SR; Tomaselli GF; O'Rourke B; Judge DP; Kass DA; Kwon C
    Cell Rep; 2017 Jan; 18(2):571-582. PubMed ID: 28076798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pluripotent stem cell-based cardiac regenerative therapy for heart failure.
    Soma Y; Tani H; Morita-Umei Y; Kishino Y; Fukuda K; Tohyama S
    J Mol Cell Cardiol; 2024 Feb; 187():90-100. PubMed ID: 38331557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of arrhythmia mechanism and burden of the infarcted ventricles following remuscularization with pluripotent stem cell-derived cardiomyocyte patches using patient-derived models.
    Yu JK; Liang JA; Franceschi WH; Huang Q; Pashakhanloo F; Sung E; Boyle PM; Trayanova NA
    Cardiovasc Res; 2022 Mar; 118(5):1247-1261. PubMed ID: 33881518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.
    Zhu W; Zhao M; Mattapally S; Chen S; Zhang J
    Circ Res; 2018 Jan; 122(1):88-96. PubMed ID: 29018036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational modeling of aberrant electrical activity following remuscularization with intramyocardially injected pluripotent stem cell-derived cardiomyocytes.
    Yu JK; Liang JA; Weinberg SH; Trayanova NA
    J Mol Cell Cardiol; 2022 Jan; 162():97-109. PubMed ID: 34487753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC-mismatched Allotransplantation of Induced Pluripotent Stem Cell-derived Cardiomyocyte Sheets to Improve Cardiac Function in a Primate Ischemic Cardiomyopathy Model.
    Kashiyama N; Miyagawa S; Fukushima S; Kawamura T; Kawamura A; Yoshida S; Eiraku S; Harada A; Matsunaga K; Watabe T; Toda K; Hatazawa J; Sawa Y
    Transplantation; 2019 Aug; 103(8):1582-1590. PubMed ID: 31107828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-mediated maturation of human pluripotent stem cell-derived cardiomyocytes: Towards a better model for cardiotoxicity?
    White MC; Pang L; Yang X
    Food Chem Toxicol; 2016 Dec; 98(Pt A):17-24. PubMed ID: 27265266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracoronary transplantation of pluripotent stem cell-derived cardiomyocytes: Inefficient procedure for cardiac regeneration.
    Kobayashi H; Tohyama S; Kanazawa H; Ichimura H; Chino S; Tanaka Y; Suzuki Y; Zhao J; Shiba N; Kadota S; Narita K; Naito T; Seto T; Kuwahara K; Shiba Y; Fukuda K
    J Mol Cell Cardiol; 2023 Jan; 174():77-87. PubMed ID: 36403760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiomyocytes derived from pluripotent stem cells: progress and prospects from China.
    Yang HT; Zhang M; Huang J; Liang H; Zhang P; Boheler KR
    Exp Cell Res; 2013 Jan; 319(2):120-5. PubMed ID: 23022397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Grown Micro-Tissues for Cardiac Cell Replacement Therapy in Vivo.
    Sahito RGA; Sheng X; Maass M; Mikhael N; Hamad S; Heras-Bautista CO; Derichsweiler D; Spitkovsky D; Suhr F; Khalil M; Brockmeier K; Halbach M; Saric T; Hescheler J; Krausgrill B; Pfannkuche K
    Cell Physiol Biochem; 2019; 52(6):1309-1324. PubMed ID: 31050280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
    Talkhabi M; Aghdami N; Baharvand H
    Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac Cell Therapy with Pluripotent Stem Cell-Derived Cardiomyocytes: What Has Been Done and What Remains to Do?
    Selvakumar D; Reyes L; Chong JJH
    Curr Cardiol Rep; 2022 May; 24(5):445-461. PubMed ID: 35275365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts.
    Chong JJ; Yang X; Don CW; Minami E; Liu YW; Weyers JJ; Mahoney WM; Van Biber B; Cook SM; Palpant NJ; Gantz JA; Fugate JA; Muskheli V; Gough GM; Vogel KW; Astley CA; Hotchkiss CE; Baldessari A; Pabon L; Reinecke H; Gill EA; Nelson V; Kiem HP; Laflamme MA; Murry CE
    Nature; 2014 Jun; 510(7504):273-7. PubMed ID: 24776797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
    Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
    Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative transcriptional signatures for evaluating the maturity degree of pluripotent stem cell-derived cardiomyocytes.
    Chen R; He J; Wang Y; Guo Y; Zhang J; Peng L; Wang D; Lin Q; Zhang J; Guo Z; Li L
    Stem Cell Res Ther; 2019 Mar; 10(1):113. PubMed ID: 30925936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts.
    Shiba Y; Gomibuchi T; Seto T; Wada Y; Ichimura H; Tanaka Y; Ogasawara T; Okada K; Shiba N; Sakamoto K; Ido D; Shiina T; Ohkura M; Nakai J; Uno N; Kazuki Y; Oshimura M; Minami I; Ikeda U
    Nature; 2016 Oct; 538(7625):388-391. PubMed ID: 27723741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem Cell Technology in Cardiac Regeneration: A Pluripotent Stem Cell Promise.
    Duelen R; Sampaolesi M
    EBioMedicine; 2017 Feb; 16():30-40. PubMed ID: 28169191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.